SOPHiA GENETICS
SOPH
32 hedge funds and large institutions have $262M invested in SOPHiA GENETICS in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
7% more funds holding
Funds holding: 30 → 32 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.27% less ownership
Funds ownership: 29.42% → 29.15% (-0.27%)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
21% less capital invested
Capital invested by funds: $331M → $262M (-$69M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
+$11.7M |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$869K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$352K |
| 4 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$285K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$209K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$7.89M |
| 2 |
Millennium Management
New York
|
-$2.85M |
| 3 |
Teacher Retirement System of Texas
Austin,
Texas
|
-$1.75M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$1.4M |
| 5 |
Morgan Stanley
New York
|
-$1.25M |
SOPH Hedge Fund Activity: Q4 2021 in Review
32 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q4 2021, worth a combined $262M — down 21% from $331M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SOPH positions and 7 closed out — a net gain of 2 holders — while 8 added to existing stakes and 10 trimmed.
The largest buyer was Jennison Associates, adding an estimated $11.7M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $7.89M sold.
- 32 institutional investors held SOPHiA GENETICS (SOPH) as of Q4 2021, up from 30 in Q3 2021.
- Funds reported $262M of SOPHiA GENETICS stock for Q4 2021, down 21% quarter-over-quarter.
- 9 funds opened new SOPHiA GENETICS positions in Q4 2021 and 7 closed out, a net change of +2 holders.
- The largest SOPHiA GENETICS buyer in Q4 2021 was Jennison Associates, an estimated $11.7M added.
- The largest SOPHiA GENETICS seller in Q4 2021 was Pura Vida Investments, an estimated $7.89M sold.
Based on aggregated 13F filings for Q4 2021.